Kepos Capital LP Incyte Corp Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $636,222 - $865,717	-10,070 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $735,512 - $963,900	10,070 New	10,070 $879,000
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $2.41 Million - $2.86 Million	-33,086 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $2.43 Million - $2.93 Million	33,086 New	33,086 $2.81 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.